November 20, 2026

INFevo Raises Over RMB 100M in Pre-A Funding

Chinese biotech-AI startup INFevo has closed a pre-A funding round exceeding RMB 100 million to advance its AI virtual-cell research, according to Unite.AI.
INFevo Raises Over RMB 100M in Pre-A Funding

Unite.AI reports that INFevo has raised more than RMB 100 million in a pre-A funding round. The company is developing AI-based virtual-cell technology, an approach that uses artificial intelligence to model and simulate cellular behavior for biological research.

According to Unite.AI, the fresh capital will be used to expand INFevo’s research into AI virtual-cell modeling. The outlet’s report did not provide further detail on the investors involved or additional specifics of the round.

The funding comes amid a broader wave of interest in applying AI and machine learning techniques to biology and drug discovery, where companies are increasingly using computational models to simulate cellular and molecular processes rather than relying solely on traditional lab experimentation.

Unite.AI’s report did not disclose additional details about INFevo’s founding team, prior funding history, or specific research milestones. InstaWire AI will provide further updates on INFevo’s work as more information becomes available.

Based on reporting by www.unite.ai.

Leave a Reply

Your email address will not be published. Required fields are marked *